Advanced Footwear Technology in Federated Athletes

April 27, 2026 updated by: Ruben Cuesta Barriuso, University of Oviedo

Use of Advanced Footwear Technology in Federated Athletes. An Ambispective Observational Study

Background. Athletics is one of the sports modalities with the greatest growth in the number of federative licenses in our country. In the last five years, the use of footwear with Advanced Footwear Technology (AFT) has become widespread in order to increase athletic performance.

Objective. To analyze the risk of injury in athletes using Advanced Footwear Technology as well as the sporting, sociodemographic and anthropometric variables that influence this risk.

Method. Ambispective cohort study. Ninety-five athletes competing in events longer than 800 meters will be recruited. The primary variable will be the number of injuries, muscular and tendon, of lower limbs in the last 3 athletic seasons. Secondary and modifying variables will be: age, sex, weekly training load with and without AFT, weekly training frequency, completion of a complementary toning program and foot size. Potential confounding variables will be body mass index, main training surface and commercial footwear models used. The analysis will calculate the risk of injury in these athletes and assess the influence of confounders and trend analysis on the primary variable, stratified by potential confounders.

Expected results. To calculate the risk of injury as a function of sport, sociodemographic and anthropometric variables. Identify

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

134

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Principality of Asturias
      • Oviedo, Principality of Asturias, Spain, 33006
        • University of Oviedo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Federated athletes competing in events over 800 meters in the Principality of Asturias.

Description

Inclusion Criteria:

  • Athletes competing in events longer than 800 meters; iii) athletes who have not undergone previous musculoskeletal surgery in the seasons under study.
  • Federated in the Federación de Atletismo del Principado de Asturias (Asturias Athletics Federation).
  • Athletes who have not undergone previous musculoskeletal surgery in the seasons under study.
  • Who were federated at least one year before the study period.

Exclusion Criteria:

  • Athletes who do not use AFT devices.
  • Athletes with a muscle or tendon injury at the time of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Athletes using advanced footwear technology
Athletes competing in events longer than 800 meters, federated in the Athletics Federation of the Principality of Asturias and using shoes with Advanced Footwear Technology. Data will be collected on the number of injuries (muscle and tendon), lower limb injuries in the last 3 athletic seasons, as well as age, sex, weekly training load with and without AFT, weekly training frequency, completion of a complementary toning program and foot size
Data will be collected on the number of injuries (muscle and tendon), lower limb injuries in the last 3 athletic seasons, as well as age, sex, weekly training load with and without AFT, weekly training frequency, completion of a complementary toning program and foot size.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the number of muscle and tendon injuries recorded by athletes in the lower limbs
Time Frame: Screening visit
Number of lower limb muscle and tendon injuries during the last 3 athletic seasons
Screening visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of age
Time Frame: Screening visit
Measurement of age (measured in years completed, by requesting the date of birth to calculate this value).
Screening visit
Assessment of gender
Time Frame: Screening visit
Measurement of gender (measured with a dichotomous variable: female / male)
Screening visit
Assessment of the weekly training load, using AFT or not
Time Frame: Screening visit
Measurement of weekly training load with and without AFT (measured in kilometers traveled)
Screening visit
Assessment of weekly training frequency
Time Frame: Screening visit
Measurement of weekly training frequency (measured in hours).
Screening visit
Assessment of the implementation of a complementary strengthening program
Time Frame: Screening visit
Measurement of the implementation of a complementary strengthening program (measured with a dichotomous variable: yes/no).
Screening visit
Assessment of the size of athletes' feet
Time Frame: Screening visit
Measurement of foot size (measured in international units)
Screening visit

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of body mass index
Time Frame: Screening visit
Measurement of body mass index (measured as kg/m2). This variable will be considered as a possible confounding variable
Screening visit
Assessment of the main training surface
Time Frame: Screening visit
Measurement of the main training surface (response options: asphalt, dirt, track and tartan). This variable will be considered as a possible confounding variable
Screening visit
Assessment of commercial footwear models used by athletes
Time Frame: Screening visit
Measurement of commercial footwear models used (response options: Nike ZoomX Vaporfly NEXT%, Nike ZoomX Alphafly NEXT%, Adidas Adizero Adios Pro, Asics Metaspeed Sky, New Balance Fuelcell SuperComp Elite, Saucony Endorphin Pro, Puma Deviate Nitro Elite, and HOKA Rocket X). This variable will be considered as a possible confounding variable
Screening visit
Assessment of athletes' weight
Time Frame: Screening visit
Assessment of athletes' weight, measured in kg.
Screening visit
Assessment of the height of the athletes
Time Frame: Screening visit
Assessment of the height of the athletes, measured in cm.
Screening visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Rubén Cuesta-Barriuso, PhD, Universidad de Oviedo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2025

Primary Completion (Actual)

April 30, 2025

Study Completion (Actual)

May 15, 2025

Study Registration Dates

First Submitted

March 25, 2025

First Submitted That Met QC Criteria

April 1, 2025

First Posted (Actual)

April 9, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe